Not all clients with CLL need therapy. In spite of all new innovations, the iwCLL however recommends watchful observation for people with asymptomatic disease.86 This advice is predicated on no less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Each trials concluded https://helenk791zay1.qodsblog.com/profile